Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Akeso, Alteogen, Alvotech, Biocon, Celltrion, Daiichi Sankyo, Eisai, Esperioin, Henlius, Innovent, Ipsen, Nuvation, Polyrizon, Verrica.